ARTICLE | Clinical News
Dasotraline: Phase II data
December 22, 2014 8:00 AM UTC
Sumitomo Dainippon’s Sunovion Pharmaceuticals Inc. subsidiary reported data from a double-blind, U.S. Phase II trial in 341 adults with ADHD showing that once-daily 8 mg dasotraline met the primary en...